Work

Breast Cancer Drug Resistance: Precision Targeting of ER and HER2 Signalling Networks

Year: 2026

Type: article

Source: Current Pharmaceutical Design

DOI: 10.2174/0113816128406867251204172244

Authors: Anitha Kuttiappan, Santenna Chenchula, Padmavathi Raja Karunakaran, Sai Varshini Talagampala, Lakshmi Sahitya Amerneni, Krishna Chaitanya Amerneni, Sunil Kumar Gupta, Shailaja Sharma, Vishnu Vardhan Karrothu, Madhu Bhargavi, Madhavrao Chavan

Institutions: Narsee Monjee Institute of Management Studies, Shri Vile Parle Kelavani Mandal, All India Institute of Medical Sciences Bhopal, Mediciti Institute of Medical Sciences, All India Institute of Medical Sciences Raipur, Guntur Medical College, University of Arizona, WellStar Health System, All India Institute of Medical Sciences, Mangalagiri

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7133128221

FWCI: 5.373

Cites:

Cited by: 2

Related to: